logo
  

CDC Panel Backs Full Approval Of Pfizer-BioNTech COVID-19 Vaccine

U.S. Centers for Disease Control and Prevention advisory panel voted to recommend the use of the Pfizer and BioNTech COVID-19 vaccine for U.S. people 16 and older.

The recommendation came a week after the U.S. Food and Drug Administration granted full approval for the vaccine in the age group.

However, the vaccine's use in adolescents 12-15 will continue to have emergency authorization until more data accumulates.

last week, Pfizer said it sought an approval from the U.S. Food and Drug Administration for its booster dose of COVID-19 vaccine.

The Pfizer/BioNTech vaccine, marketed as Comirnaty, had been authorized for emergency use in the US since last December for people age 16 and older. In May, the authorization was extended to those 12 and older.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Privately-held biotechnology company On Target Laboratories, Inc. announce that the U.S. Food and Drug Administration or FDA, has approved Cytalux (pafolacianine) for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. Cytalux is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively. The Federal Trade Commission or FTC has ordered Walmart, Amazon, Kroger and certain other large wholesalers and suppliers to provide information to help it study causes of supply chain disruptions. The agency has launched an inquiry to find the reasons for empty shelves and exorbitant prices. Along with Walmart, Amazon.com, and Kroger, the order has been sent to C&S Wholesale Grocers, Associated.. Covid vaccine maker Moderna Inc.'s Chief Executive Stéphane Bancel has predicted that existing COVID-19 vaccines will be much less effective against Omicron than earlier strains, according to the Financial Times.
Follow RTT